Genomics4S

While the recent adoption of a flexible clinical translation model in Hainan Province promises to accelerate biomedical innovation in China, it has also intensified concerns about patient safety, transparency, and misinformation. The success of this new approach is largely dependent on strengthening post-market oversight, access to clinical data, and strategic alignment with international bioethical guidelines.

Media representations of regenerative medicine across countries and continents have consistently conveyed an overtly optimistic view on the

Press release A new study released today suggests that draft amendments proposed by India's Central Drugs Standard Control Organization...